Featured event

Sun, 23 Jul 2023 - Thu, 27 Jul 2023
The 12th IAS Conference on HIV Science
IAS 2023, the 12th IAS Conference on HIV Science, will take place in Brisbane, Australia, and virtually from 23 to 26 July 2023. IAS 2023, being held at the Brisbane Convention and Exhibition Centre, will shine a spotlight on the world’s advances in HIV research.
More upcoming events

22 Jul 2023
Putting people first in the prevention, treatment and care of HPV-related cancers among people living with HIV
IAS – the International AIDS Society – and its partners are organizing a one-day pre-meeting, titled “Putting people first in the prevention, treatment and care of HPV-related cancers for people living with HIV”, in conjunction with IAS 2023, the 12th IAS Conference on HIV Science. The event will be held at the Pullman & Mercure King George Square Hotel, Corner of Ann & Roma Street, Brisbane, 4000, Australia, on 22 July 2023. The content will be accessible online after the pre-meeting. This pre-meeting will be of interest to HIV basic scientists, clinicians, researchers, public health practitioners, implementers, community advocates and those working towards preventing and managing HPV-related cancers. People with HIV experience a substantially increased incidence of cancers associated with human papillomavirus (HPV), including cervical cancer, anal cancer, other anogenital cancers and oro-pharyngeal cancer. Globally, cervical cancer is the most common cancer in women living with HIV, and people living with HIV are more likely to develop cervical cancer at a younger age. Scale up of HPV vaccination, screening and treatment are required to meet the ambitious targets of the World Health Organization to eliminate cervical cancer as a public health problem by 2030. People living with HIV should be prioritized in this scale up. Anal cancer is a common cancer in people living with HIV and is among the most common of all cancers in men having sex with men living with HIV. Like cervical cancer, future anal cancer cases will eventually be prevented by HPV vaccination of children. In addition, screening in people living with HIV, analogous to the cervical model, has been proposed. In 2022, a large, randomized trial reported for the first time that treatment of screen-detected pre-cancer reduced the incidence of anal cancer. Clinical societies will need to adjust to these new results and the reality that screening and treatment to prevent anal cancer is needed in people living with HIV. The objective of the meeting is to bring together a diverse group of scientific, technical and community representatives to discuss current opportunities and challenges for increased prevention and screening for HPV, as well as diagnosis and treatment of intraepithelial neoplasia to prevent cervical cancer and anal cancer in people living with HIV and other populations. Programme and Organizing Committee Adeeba Kamarulzaman, Universiti Malaya, Malaysia Andrew Grulich, Kirby Institute, University of NSW, Australia Joel Palefsky, University of California San Francisco, United States Sinead Delany-Moretlwe, University of the Witwatersrand, South Africa Programme overview 09:00 – 10:00 Session 1 – Welcome and introduction: The scale of the challenges 10:10 – 10:30 Break 10:30 – 12:00 Session 2 – State-of-the-art guidance for vaccination, screen and treat 12:00 – 13:00 Lunch provided on site 13:00 – 14:30 Session 3 – Good-practice models for HPV cancer elimination 14:30 – 15:00 Break 15:00 – 16:00 Session 4 – Discussion: Current and future research gaps related to HPV cancer elimination 16:00 – 16:15 Break 16:15 – 17:00 Session 5 – Discussion: Call to action 17:00 – 18:00 Networking reception Registration To encourage the broadest participation in the pre-meeting, registration will be free. However, the meeting will be in person only and limited to 250 attendees. Stay tuned. Registration opens soon! Please note that registration for the IAS 2023 pre-meeting: Person-centred HIV and HPV care does not grant you access to IAS 2023. Proudly supported by gold sponsor: With support from: table.table-fix { table-layout: fixed; margin-top: 32px; margin-bottom: 48px; } table.table-fix tr td { padding: 12px 16px; border-right: 2px solid #fff; } table.table-fix tr:nth-child(2n) td { background-color: #f2f5f6; }
View details View details
22 Jul 2023
2023 HIV Cure & Immunotherapy Forum
The 2023 HIV Cure & Immunotherapy Forum, organized by the IAS Towards an HIV Cure initiative, will be held at the Brisbane Convention & Exhibition Centre in Brisbane, Australia, on 22 July 2023 alongside IAS 2023, the 12th IAS Conference on HIV Science. The content of the Forum will be accessible online after the meeting. Following the success of the 2019 HIV & HBV Forum and the 2021 HIV Cure and Gene Therapy Forum, the 2023 Forum will focus on the intersection between immunotherapy and HIV cure research, building on recent advances in both fields. Its main goals are to establish a unified definition for post-intervention control, understand the biological impact of immunotherapies for cure, understand the underlying mechanisms, and learn from advances in immunotherapies in cancer therapeutics and vaccine development. The Forum will include invited speakers, an oral abstract discussion and a panel discussion incorporating perspectives from both fields and highlighting current research directions. Forum objectives Accelerate research on immunotherapy curative strategies. Create an environment to foster interdisciplinary collaborations and merge the HIV cure and immunotherapy disciplines. Provide an opportunity for the next generation of investigators to launch their careers through interaction and discussion with peers. Promote engagement of researchers, advocates, social and behavioural scientists, ethicists, philanthropic organizations and the private sector and seek to promote research in low- and middle-income settings. Promote increased investments in cure research. Provide a platform for information sharing, debate and networking among peers. Programme Committee Thumbi Ndung'u, Beatriz Mothe Pujadas and Anthony Kelleher will co-chair the meeting. The Forum Programme Committee will be made up of experts from both fields and include Sharon Lewin and Steve Deeks, the inaugural Co-Chairs of the IAS Towards an HIV Cure forums. We will provide more information about the scientific programme soon. Registration To encourage the broadest participation in the forum, registration will be free. However, the meeting will be in person only and limited to 300 attendees. Stay tuned. Registration opens soon! Please note that registration for the 2023 HIV Cure & Immunotherapy Forum does not grant you access to IAS 2023.
View details View details
22 - 26 Jul 2024
The 25th International AIDS Conference
AIDS 2024, the 25th International AIDS Conference, will take place in Munich, Germany, and virtually from 22 to 26 July 2024 and is expected to bring together some 18,000 participants from around the world.
View details View details
6 - 10 Oct 2024
The 5th HIV Research for Prevention Conference
HIVR4P 2024, the 5th HIV Research for Prevention Conference will take place in Lima, Peru, and virtually from 6 to 10 October 2024 and is expected to bring together around 1,500 participants.
View details View detailsLatest news
14 Feb 2023
IAS announces global rotation of all its conferences
Munich, Germany, will host AIDS 2024; the IAS will invite bids from Africa for IAS 2025 and from Latin America and the Caribbean for AIDS 2026 14 February 2023 (Geneva, Switzerland) – IAS – the International AIDS Society – today announced that the International AIDS Conference, the IAS Conference on HIV Science and the HIV Research for Prevention Conference will rotate to all regions of the world and that conferences will continue to offer virtual participation. The in-person component of IAS conferences will rotate among five world regions – Africa, Asia and the Pacific, Europe, Latin America and the Caribbean, and the US and Canada – and will not take place consecutively in any region. AIDS 2024, the 25th International AIDS Conference, will take place in Munich, Germany, and virtually from 22 to 26 July 2024. Pre-conferences are set to start on 20 July 2024. “The global rotation will help ensure that people from around the world have an opportunity to participate in our conferences in person. It will also allow us to shine a spotlight on critical HIV issues in every region,” IAS President Sharon Lewin said. “AIDS 2024 will welcome people living with, affected by and working on HIV from around the world to gather and accelerate an HIV response that puts people first.” The IAS will invite bids from potential host cities in Africa for IAS 2025, the 13th IAS Conference on HIV Science, and from cities in Latin America and the Caribbean for AIDS 2026, the 26th International AIDS Conference. Additionally, the IAS will continue to offer virtual access to delegates around the world and work to provide thousands of scholarships to keep its conferences inclusive. Due to Munich’s proximity to eastern Europe with its rapidly growing HIV epidemic, AIDS 2024 will feature a third Co-Chair, Andriy Klepikov, representing eastern Europe. Klepikov will join International Co-Chair Sharon Lewin and Local Co-Chair Christoph Spinner. “Munich – Kyiv’s official partner city – offers a safe and welcoming space for conference delegates who hail from this region and beyond, including people living with and affected by HIV,” Andriy Klepikov said. “AIDS 2024 will provide an opportunity to shine a spotlight on one of the fastest-growing HIV epidemics in the world, driven by a lack of access to health services for people who use drugs and exacerbated by the disruption and instability of the war in Ukraine, mass migration and faltering economies.” “Germany is proud to host AIDS 2024, the 25th International AIDS Conference, and to welcome the global HIV community in all its diversity to the beautiful city of Munich,” Germany’s Federal Minister of Health Karl Lauterbach said. “The alarming and fast-rising rates of new HIV acquisitions in eastern Europe are a powerful reminder that the epidemic is far from being over in our wider region. As UNAIDS reports, without addressing inequalities and structural barriers to accessing services, we will not meet global targets on AIDS. Our goal is to leverage AIDS 2024 as an opportunity to address these challenges head on.” “Munich will provide a welcoming environment for the worlds of science and policy and especially for marginalized people to come together to exchange knowledge and ideas without fearing for their health and safety,” Local Co-Chair Christoph Spinner said. “Munich’s HIV response, specifically, has had excellent outcomes and we look forward to sharing our evidence-based approach that puts people first with the rest of the world.” Background on conference location selection The IAS Conference Committee and the IAS Executive Board review bids from potential host cities and make the final selection of the host cities for IAS conferences. The committee considers bids and selects the conference location based on six key criteria used to evaluate the potential host city’s ability to: Safeguard the rights of delegates, especially key populations Advance the local and/or global response Meet the health needs of our delegates, many of whom are immunocompromised Meet infrastructure and access needs for conferences for up to 20,000 people Remain independent from outside pressure Ensure the long-term viability of the conference Additionally, as part of its commitment to inclusivity, the IAS affirmed that AIDS 2024 and future IAS conferences will: Offer virtual participation for those unable or who do not wish to attend in person Provide thousands of scholarships to ensure that travel and cost barriers don’t prevent people from the most affected regions of the world from attending Offer registration rates for young people and people from lower-income countries up to 90% below the full registration fee Continue bringing the latest science emerging at the conference to various locations around the globe – at no cost to participants – through the IAS Educational Fund Provide free online access to all major conference sessions one month after the conference for IAS Members and two months after the conference for the general public # # # About the IAS IAS – the International AIDS Society – convenes, educates and advocates for a world in which HIV no longer presents a threat to public health and individual well-being. After the emergence of HIV and AIDS, concerned scientists created the IAS to bring together experts from across the world and disciplines to promote a concerted HIV response. Today, the IAS and its members unite scientists, policy makers and activists to galvanize the scientific response, build global solidarity and enhance human dignity for all those living with and affected by HIV. The IAS also hosts the world’s most prestigious HIV conferences: the International AIDS Conference, the IAS Conference on HIV Science and the HIV Research for Prevention Conference. Find out more at https://www.iasociety.org. Media contact [email protected]
Read more IAS announces global rotation of all its conferences